Rick,
The interesting news of the day:
biz.yahoo.com
Not much reaction out there. The info doesn't say very much, except how did ORG manage to have such a good heal rate in the hard to heal ulcers using current gold standard approaches...raises the question of what the severity level of the ulcers was.
Also, the techvest report reminder today came out, simply touting their picks and their performances, including ATIS. Also, over the last few days, for those who haven't seen, Forbes (5/3) has a bit story about tissue engineering, primarily about cartilage, with a big blurb about ATIS, and the earlier part of the article primarily focusing on GZTC's carticel, including its plusses and minuses.
Happy almost Tuesday.
Marshall |
